Key result
Contemporary risk assessment scores effectively stratify ischemic and bleeding risks in acute coronary syndromes.
Systematic Review
Provides a comprehensive overview of modern clinical risk scores to aid in the optimal risk stratification and management of ACS patients.
This article presents an overview of contemporary risk assessment systems used in patients with myocardial infarction. The full range of risk scales, both recommended by the European Society of Cardiology and others published in recent years, is presented. Scales for assessing the risk of ischemia/death as well as for assessing the risk of bleeding are presented. A separate section is devoted to systems assessing the integrated risk associated with both ischemia and bleeding. In the first part of the work, each of the risk scales is described in detail, including the clinical trials/registers on the basis of which they were created, the statistical methods used to develop them, as well as the specification of their individual parameters. The next chapter presents the practical application of a given scale in the patient risk assessment process, the timing of its application on the timeline of myocardial infarction, as well as a critical assessment of its potential advantages and limitations. The last part of the work is devoted to the presentation of potential directions for the development of risk assessment systems in the future.
No takes yet. Share an insight, caveat, or question.
Gawiński et al. (2021) conducted a systematic review in Acute Coronary Syndromes (ACS). Clinical risk assessment scores (e.g., TIMI, GRACE, CRUSADE) was evaluated. This systematic review comprehensively describes contemporary risk assessment scales used to evaluate ischemic and bleeding risks in patients with acute coronary syndromes to guide clinical practice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: